Skip to main content

Table 4 Adjusted logistic mixed-effects models of predictive factors for 30-day mortality

From: Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study

 

Model 1

Model 2

Model 3

All cohort

Admitted for UTI

Admitted for other condition

OR

95% CI

p

OR

95% CI

p

OR

95% CI

p

Fixed parts

 (Intercept)

0.08

0.04–0.16

< 0.001

0.02

0.01–0.08

< 0.001

0.07

0.03–0.18

< 0.001

 CA-UTI

1.40

0.77–2.54

0.269

1.62

0.63–4.15

0.314

1.24

0.54–2.81

0.610

 Male gender

0.53

0.31–0.90

0.019

0.31

0.12–0.80

0.016

0.77

0.40–1.51

0.450

 Age

1.57

1.12–2.19

0.009

1.69

0.93–3.05

0.084

1.57

1.03–2.39

0.036

 Haematologic malignancy

6.08

1.84–20.07

0.003

2.33

0.19–29.45

0.512

14.82

2.83–77.61

0.001

 Charlson score

1.45

1.12–1.88

0.005

1.28

0.83–1.96

0.257

1.64

1.16–2.33

0.005

 Bedridden functional capacity

2.48

1.39–4.43

0.002

3.10

1.13–8.50

0.028

2.00

0.94–4.28

0.073

 Acquisition in a medical care facility

1.73

0.93–3.23

0.085

1.58

0.63–3.95

0.327

1.71

0.69–4.25

0.247

 Admission reason: other condition than UTI

2.70

1.40–5.00

0.003

      

Random effects

 τ00

0.37

0.96

0.24

 ICC

0.1

0.23

0.09

 Observations

807

474

333

 Marginal R2/Conditional R2

0.278/0.350

0.210/0.389

0.223/0.292

  1. UTI urinary tract infection, OR odds ratio, 95%CI 95% confidence interval, CA-UTI catheter-associated urinary tract infection, ICC intra-class correlation